2021
A New England COVID-19 Registry of Patients With CNS Demyelinating Disease
Money KM, Mahatoo A, Samaan S, Anand P, Baber U, Bailey M, Bakshi R, Bouley A, Bower A, Cahill J, Houtchens M, Katz J, Lathi E, Levit E, Longbrake EE, McAdams M, Napoli S, Raibagkar P, Wade P, Sloane JA. A New England COVID-19 Registry of Patients With CNS Demyelinating Disease. Neurology Neuroimmunology & Neuroinflammation 2021, 8: e1046. PMID: 34341094, PMCID: PMC8362350, DOI: 10.1212/nxi.0000000000001046.Peer-Reviewed Original ResearchConceptsCOVID-19 infectionHospitalization ratesRisk factorsSevere coronavirus disease 2019 (COVID-19) infectionDisease-modifying therapy useCoronavirus disease 2019 (COVID-19) infectionStepwise multivariate logistic regressionCNS Demyelinating DiseaseNausea/vomitingAbsolute lymphocyte countIndependent risk factorNumber of comorbiditiesDisease 2019 infectionPatient risk factorsRisk of hospitalizationCOVID-19 cohortDisease-modifying therapiesCase fatality rateMultivariate logistic regressionCOVID-19 registryFisher's exact testDemyelinating diseaseClinical characteristicsLymphocyte countNeurologic symptoms
2016
Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis
Longbrake EE, Lancia S, Tutlam N, Trinkaus K, Naismith RT. Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis. Multiple Sclerosis And Related Disorders 2016, 10: 198-203. PMID: 27919490, PMCID: PMC5392253, DOI: 10.1016/j.msard.2016.10.009.Peer-Reviewed Original ResearchConceptsRetinal nerve fiber layerOptic neuritisVisual dysfunctionMS patientsContrast chartsVisual fieldVFQ-25 scoresPelli-Robson contrast sensitivity chartNerve fiber layerSevere visual dysfunctionSnellen eye chartLow contrast chartsCross-sectional studyContrast sensitivity testQuality of lifeContrast sensitivity chartLow-contrast testsOptical coherence tomographyMultiple sclerosisVisual acuityElectrophysiologic functionPatientsEye chartPR chartNeuritis
2008
Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats
Detloff MR, Fisher LC, McGaughy V, Longbrake EE, Popovich PG, Basso DM. Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Experimental Neurology 2008, 212: 337-347. PMID: 18511041, PMCID: PMC2600773, DOI: 10.1016/j.expneurol.2008.04.009.Peer-Reviewed Original ResearchConceptsPeripheral nerve injuryL5 dorsal hornRemote microglial activationLevel allodyniaPro-inflammatory cytokinesMicroglial activationNeuropathic painNerve injuryDorsal hornLevel painPro-inflammatory cytokine productionActivator of microgliaLevel neuropathic painRobust microglial activationChronic time pointsSpinal cord injuryLevel of injuryAllodynic ratsChronic allodyniaModerate SCISupraspinal centersCord injuryCytokine productionIL-6IL-1beta